Julie Brown
Chief Financial Officer and Executive Director, GSK & Non-Executive Director, Diageo
Diageo•London Area, United Kingdom
View LinkedIn ProfileExperience38+ Years
LevelLeadership
Executive Overview
CFO of GSK COO and CFO Burberry plc CFO of Smith & Nephew plc Member of the Board of Roche and Audit Committee Chair Interim CFO and VP Group Finance of AstraZeneca plc Regional Commercial Vice President of AstraZeneca Latin America ($1.6bn revenue; 3,200 people) Country President of Portugal AstraZeneca ($240m revenue) AstraZeneca: VP Finance positions in all aspects of healthcare value chain KPMG: Fellow of the Institute of Chartered Accountants KPMG: Fellow of the Institute of Taxation
Career Timeline
- DiageoCurrentAug 2024–Present· 2 yrs 1 mo
- Non-Executive DirectorCurrentAug 2024–Present
- GSKCurrentApr 2023–Present· 3 yrs 5 mos
- Chief Financial Officer and Executive DirectorCurrentApr 2023–Present
- 2017–Jun 2023· 6 yrs 5 mos
- Chief Operating and Chief Financial Officer2017–Jun 2023
- Mar 2016–Jun 2023· 7 yrs 3 mos
- Member, Board of DirectorsMar 2016–Jun 2023
- Feb 2013–2017· 3 yrs 11 mos
- CFOFeb 2013–2017
- Nov 1987–2013· 25 yrs 2 mos
- Regional Commercial Vice President Latin AmericaApr 2010–Jul 2012
- Marketing Company PresidentJun 2008–Apr 2010
- VP Corporate StrategyMar 2006–Jun 2008
- VP Finance and Strategy OperationsMar 2003–Mar 2006
- VP Finance, Global MarketingMar 1999–Mar 2002
- Interim CFO and VP Group FinanceNov 1987–2013
Education
Advanced Management Program
Business Management
INSEADTaxation
Institute of TaxationACA (Chartered Accountant)
Finance and Business
ICAEWBA First Class Honours
University of WarwickExecutive Relationship Map
Reports To
Julie Brown
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
Change ManagementFinancial AnalysisRisk ManagementSales EffectivenessRestructuringBusiness PlanningFinancial ModelingStrategyDue DiligenceStrategic PlanningCross-functional Team LeadershipBusiness StrategyStrategic ThinkingBudgetsMergersPharmaceutical SalesManagerial FinancePharmaceutical IndustryForecastingMarket Access